Have a personal or library account? Click to login
Clinical risk scores for the prediction of incident atrial fibrillation: a modernized review Cover

Clinical risk scores for the prediction of incident atrial fibrillation: a modernized review

Open Access
|Nov 2021

References

  1. 1. BENJAMIN A., LEVY D., VAZIRI SM., D’AGOSTINO RB., BELANGER AJ., WOLF P. Independent risk factors for atrial fibrillation in a population based cohort study. JAMA 1994, Vol. 271, No.11.10.1001/jama.1994.03510350050036
  2. 2. GO A.S., HYLEK E.M, PHILLIPS K.A., YUCHIAO C., HENAULT L.E., SELBY J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370–5.10.1001/jama.285.18.237011343485
  3. 3. WILLIAMS BA, CHAMBERLAIN AM, BLANKENSHIP JC, HYLEK EM, VOYCE S, Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018. JAMA Netw Open. 2020;3(8):e201487410.1001/jamanetworkopen.2020.14874745585532857147
  4. 4. SOLIMAN E.Z., SAFFORD M.M., MUNTNER P., KHODNEVA Y., FARAH Z. DAWOOD FZ., et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014;174:107–14.10.1001/jamainternmed.2013.11912411528224190540
  5. 5. O’NEAL W.T., QURESHI W., ZHANG Z.M. Bidirectional association between atrial fibrillation and congestive heart failure in the elderly. J Cardiovasc Med (Hagerstown) 2016;17:181–6.10.2459/JCM.000000000000028926825329
  6. 6. ALONSO A., ALMUWAQQAT Z., CHAMBERLAIN A. Mortality in atrial fibrillation. Is it changing? [published online ahead of print, 2020 Oct 27]. Trends Cardiovasc Med. 2020;S1050–1738(20)30133-X.
  7. 7. SCHNABEL RB, LARSON MG, YAMAMOTO JF, SULLIVAN LM., PENCINA MJ., MEIGS JB., et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010;121(2):200–207.10.1161/CIRCULATIONAHA.109.882241322482620048208
  8. 8. LIN L, SELVIN E, LUTSEY P, HOOGEVEEN R, O’NEAL W., SOLIMAN E.Z., et al. Association of N-terminal pro B-type natriuretic peptide change with the risk of atrial fibrillation in the ARIC cohort. Am Heart J 2018;204:119–127.10.1016/j.ahj.2018.07.008621472830099337
  9. 9. CHAMBERLAIN AM, AGARWAL SK, FOLSOM AR, SOLIMAN EZ, CHAMBLESS LE, CROW R. et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011; 107(1):85–91.10.1016/j.amjcard.2010.08.049303113021146692
  10. 10. ALONSO A, KRIJTHE BP, ASPELUND T, STEPAS KA, PENCINA MJ, MOSER CB, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013; 2(2):e000102.10.1161/JAHA.112.000102364727423537808
  11. 11. Swedish Cohort Consortium (Cohorts.se) (2011). Malmö Diet Cancer (Identifier AND-ID: EXT 0012). Retrieved from https://snd.gu.se/en/catalogue/study/ext0012 (last accessed: 11/11/2020).
  12. 12. SMITH JG, PLATONOV PG, HEDBLAD B, ENGSTROM G, MELANDER O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010 Feb;25(2):95-102.10.1007/s10654-009-9404-119936945
  13. 13. SCHNABEL RB, LARSON MG, YAMAMOTO JF, SULLIVAN LM, PENCINA MJ, MEIGS JB, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010;121(2):200–207.10.1161/CIRCULATIONAHA.109.882241322482620048208
  14. 14. LI YG, PASTORI D., FARCOMENI A, YANG PS, JANG E, JOUNG B., et al. A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. CHEST 2019; 155(3):510–518.10.1016/j.chest.2018.09.011643702930292759
  15. 15. CHAO TF, LIU CJ, CHEN SJ, WANG KL, LIN YJ, CHANG SL, et al., CHADS2 score and risk of new-onset atrial fibrillation: A nationwide cohort study in Taiwan. International Journal of Cardiology 168 (2013) 1360–1363.
  16. 16. SUENARI K., CHAO TF., LIU CJ. KIHARA Y., CHEN TJ., CHEN SA. Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians. Medicine (2017) 96:1(e5597).10.1097/MD.0000000000005597522865728072697
  17. 17. KOKUBO Y., WATANABE E., HIGASHIYAMA A., NAKAO YM., KUSANO K., MIYAMOTO Y. Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population – The Suita Study – Circ J 2017; 81: 1580–1588.
  18. 18. SMITH JG., NEWTON-CHEH C., ALMGREN P, STRUCK J., MORGENTHALER NG., BERGMANN A., et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol. 2010;56(21):1712–1719.10.1016/j.jacc.2010.05.049300532421070922
DOI: https://doi.org/10.2478/rjim-2021-0018 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 321 - 327
Submitted on: Nov 13, 2020
Published on: Nov 20, 2021
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Anna Maria Louka, Christos Tsagkaris, Alexandra Stoica, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.